Insider Buying: Dominari (NASDAQ:DOMH) CEO Purchases 50,000 Shares of Stock

Dominari Holdings Inc. (NASDAQ:DOMH) CEO Anthony Hayes acquired 50,000 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The stock was purchased at an average cost of $2.02 per share, for a total transaction of $101,000.00. Following the purchase, the chief executive officer owned 4,550,873 shares of the company’s stock, valued at $9,192,763.46. This represents a 1.11% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Dominari Price Performance

DOMH opened at $2.18 on Monday. The stock’s fifty day moving average is $2.56 and its two-hundred day moving average is $2.92. The company has a market capitalization of $52.84 million, a P/E ratio of -0.40 and a beta of 0.87. Dominari Holdings Inc. has a 52 week low of $1.91 and a 52 week high of $8.40.

Dominari (NASDAQ:DOMH) last announced its quarterly earnings results on Monday, August 10th. The company reported ($0.21) earnings per share for the quarter, topping the consensus estimate of ($0.34) by $0.13. Dominari had a negative net margin of 51.61% and a negative return on equity of 235.37%. The firm had revenue of $16.79 million during the quarter, compared to analysts’ expectations of $16.79 million.

Analysts Set New Price Targets

Several research firms have commented on DOMH. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Dominari in a report on Monday, July 6th. Wall Street Zen lowered Dominari from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Dominari has a consensus rating of “Sell”.

Hedge Funds Weigh In On Dominari

A number of hedge funds have recently bought and sold shares of DOMH. Creek Drive Management Group LLC acquired a new stake in Dominari in the fourth quarter valued at approximately $1,861,000. Geode Capital Management LLC raised its stake in shares of Dominari by 8.9% during the 4th quarter. Geode Capital Management LLC now owns 88,293 shares of the company’s stock worth $437,000 after buying an additional 7,244 shares during the period. Renaissance Technologies LLC purchased a new position in shares of Dominari during the 4th quarter valued at approximately $412,000. Millennium Management LLC acquired a new stake in Dominari in the 3rd quarter valued at $213,000. Finally, Susquehanna Advisors Group Inc. purchased a new stake in Dominari in the 4th quarter worth $182,000. Hedge funds and other institutional investors own 42.48% of the company’s stock.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.